Cellibre
PrivateCompany Overview
Cellibre is a biotechnology company that employs an organism-agnostic approach, precision fermentation, and AI-driven engineering to manufacture bio-based ingredients for the pharmaceutical, beauty, and nutraceutical industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellibre Comparables
Compare Cellibre with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CB Therapeutics | 87% | |
| Conagen | 86% | |
| Biomedican | 85% | |
Cellibre Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Cellibre Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cellibre's valuation, stock price, and market status.